Using the International Pandemic Instrument to Revitalize the Innovation Ecosystem for Antimicrobial R&D
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Using the International Pandemic Instrument to Revitalize the Innovation Ecosystem for Antimicrobial R&D . / Morales Caceres, Andrea; Kumar Singh, Kshitij ; Minssen, Timo; Hoffman, Steven J. ; Van Katwyk, Susan Rogers.
I: Journal of Law, Medicine & Ethics, Bind 50, Nr. S2 (Winter 2022), 2022, s. 47-54.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Using the International Pandemic Instrument to Revitalize the Innovation Ecosystem for Antimicrobial R&D
AU - Morales Caceres, Andrea
AU - Kumar Singh, Kshitij
AU - Minssen, Timo
AU - Hoffman, Steven J.
AU - Van Katwyk, Susan Rogers
PY - 2022
Y1 - 2022
N2 - The inclusion of antimicrobial resistance (AMR) and increased research and development (R&D) capabilities in the most recent outline of the World Health Organization’s (WHO’s) international pandemic instrument signals an opportunity to reshape pharmaceutical R&D system in favour of antimicrobial product development. This article explains why the current innovation ecosystem has disadvantaged the creation of antimicrobial products for human use. It also highlights how the COVID-19 pandemic experience can inform and stimulate international cooperation to implement innovative R&D incentives to bring new, life-saving antimicrobial products to the market.
AB - The inclusion of antimicrobial resistance (AMR) and increased research and development (R&D) capabilities in the most recent outline of the World Health Organization’s (WHO’s) international pandemic instrument signals an opportunity to reshape pharmaceutical R&D system in favour of antimicrobial product development. This article explains why the current innovation ecosystem has disadvantaged the creation of antimicrobial products for human use. It also highlights how the COVID-19 pandemic experience can inform and stimulate international cooperation to implement innovative R&D incentives to bring new, life-saving antimicrobial products to the market.
KW - Faculty of Law
KW - AMR
KW - pandemic treaty
KW - law
KW - ethics
U2 - 10.1017/jme.2022.79
DO - 10.1017/jme.2022.79
M3 - Journal article
C2 - 36889345
VL - 50
SP - 47
EP - 54
JO - Journal of Law, Medicine & Ethics
JF - Journal of Law, Medicine & Ethics
SN - 1073-1105
IS - S2 (Winter 2022)
ER -
ID: 312845009